Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Takeda UK Limited, 1 Kingdom Street, London, W2 6BD, United Kingdom
Protium i.v. 40 mg powder for solution for injection.
Pharmaceutical Form |
---|
Powder for solution for injection. White to off-white powder. |
Each vial contains 40 mg of pantoprazole.
Excipients with known effect:
Each vial contains 1 mg disodium edetate and 0.24 mg sodium hydroxide.
This medicinal product contains less than 1 mmol sodium (23 mg) per vial, i.e. is essentially ‘sodium-free’.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pantoprazole |
Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. |
List of Excipients |
---|
Disodium edetate |
10 ml clear glass (type I) vial with aluminium cap and grey rubber stopper containing 40 mg powder for solution for injection.
Pack sizes of 1 vial and 5 (5x1) vials with powder for solution for injection.
Hospital packs: 1 vial, 5 (5x1) vials, 10 (10x1) vials and 20 (20x1) vials with powder for solution for injection.
Not all pack sizes may be marketed.
Takeda UK Limited, 1 Kingdom Street, London, W2 6BD, United Kingdom
PL 16189/0036
Date of first authorisation: 20/03/1998
Date of last renewal: 31/07/2007
Drug | Countries | |
---|---|---|
PROTIUM | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.